Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of IMMUNOME INC
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
10
0
0
0
No Price
01.05.2026 21:38
Current Prices from IMMUNOME INC
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
IMNM
USD
01.05.2026 21:38
22,72 USD
-0,22 USD
-0,96 %
IEX
IMNM
USD
01.05.2026 19:59
22,73 USD
-0,21 USD
-0,94 %
Share Float & Liquidity
Free Float82,90 %
Shares Float72,83 M
Shares Outstanding87,86 M
Company Profile for IMMUNOME INC Share
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
